Marijuana is an ancient plant, but we’re only beginning to unravel its DNA

1-30-2019 med pot
Image credit: Prague Pot

For a plant humans have grown and transported around the world for thousands of years—utilizing its precious seeds, flowers, resin, and fibers in myriad ways—we sure don’t know much about cannabis. Only recently have scientists begun to identify its chemical compounds and other properties with any degree of accuracy. Patients and doctors have designed their own ad hoc treatments, but serious clinical trials are few and far between, both in the U.S. and abroad.

As scientists and researchers begin to unravel the tangled and convoluted codes of cannabis genotypes, new light is shed on the most infamously hybridized plant on the planet. For farmers and breeders who want to settle scores, DNA-mapping projects will provide more clarity about what’s what in the cannasphere and who really developed some of the industry’s most prized strains.

Mowgli Holmes has been working to map cannabis genotypes at his Portland, Oregon, company Phylos since 2014. As cannabis growers across the world send samples for testing, Phylos employs modern molecular genetics and computational biology to create a “galaxy” visually representing hundreds of cannabis cultivars and how they relate to each other….

Read full, original article: The Cannabis Plant: an Unfolding Story in Genetics

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT-Image-May-13-2026-11_56_08-AM
After slashing global health aid by $19 Billion, Trump moves to tap $2.1 billion more—to cover shutdown costs
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
ChatGPT Image May 12, 2026, 10_19_00 AM 2
Viewpoint— 'Muscular governance': How authoritarianism is surging corporate-linked energy misinformation
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.